đź“‹ FDA Reference

glucocard r w onyx blood glucose monitoring system

Arkray Factory

Summary: The Glucocard R W Onyx Blood Glucose Monitoring System is a device used to measure blood glucose levels, primarily for patients with diabetes. It is typically used by endocrinologists, diabetologists, and patients themselves for self-monitoring.

FDA Clearance Information

Pathway 510K
Decision Date April 10, 2019
Product Code NBW
Device Class Class 2
Evidence 40 studies

The Glucocard R W Onyx Blood Glucose Monitoring System was cleared through the FDA 510(k) pathway on April 10, 2019. Manufactured by Arkray Factory, it is classified as a Class 2 medical device.

What It Is

The Glucocard R W Onyx is a blood glucose monitoring system designed to provide accurate and quick readings of blood glucose levels. It works by using a small blood sample, typically obtained via a fingerstick, which is then analyzed by the device to provide a glucose reading. This device is essential for managing diabetes, allowing patients and clinicians to monitor and adjust treatment plans effectively.

Clinical Applications

This device is commonly used in both clinical and home settings for the management of diabetes. It is particularly useful in endocrinology and primary care settings, where regular monitoring of blood glucose is crucial for patient care. Patients with diabetes, both Type 1 and Type 2, rely on such devices for daily monitoring to prevent complications and manage their condition effectively.

Indications for Use

The FDA indications for this device focus on its use for monitoring blood glucose levels in patients with diabetes. It is intended for individuals who need to regularly check their blood sugar levels to manage their condition effectively.

Practical Considerations

The Glucocard R W Onyx is typically compact and portable, making it convenient for both clinical and personal use. It is compatible with standard lancets and test strips, and users should be familiar with proper technique to ensure accurate readings. Regular calibration and maintenance are recommended to maintain device accuracy.

Linked Studies (20)

PubMed • 2026

Peripheral Vasculature Embolization with the Onyx Liquid Embolic System in a Swine Model.

Journal of vascular and interventional radiology : JVIR

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Embolization of middle meningeal artery for chronic subdural hematoma: Do we have sufficient evidence?

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent.

American heart journal

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

OnyxTMGel or Coil versus Hydrogel as Embolic Agents in Endovascular Applications: Review of the Literature and Case Series.

Gels (Basel, Switzerland)

View Source →
PubMed • 2024

The resolute Onyx in TIA management (ROTIA).

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Spinal tumor embolization with Onyx: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2024

Technical video: Onyx-18 embolization of spinal epidural arteriovenous Fistula using the scepter-Mini balloon catheter.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

DynamX sirolimus-eluting Bioadaptor versus the zotarolimus-eluting Resolute Onyx stent in patients with de novo coronary artery lesions: Design and rationale of the multi-center, international, randomized BIODAPTOR-RCT.

Cardiovascular revascularization medicine : including molecular interventions

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Delayed Migration of Onyx Embolic Agent after Preoperative Embolization of an Arteriovenous Malformation in a Pediatric Patient: A Case Report and Review of the Literature.

Pediatric neurosurgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

The Era of Onyx Embolization: A Systematic and Literature Review of Preoperative Embolization Before Stereotactic Radiosurgery for the Management of Cerebral Arteriovenous Malformations.

World neurosurgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2023

Torcular dural AVF: Transvenous onyx embolisation with sinus reconstruction.

Clinical neurology and neurosurgery

View Source →
PubMed • 2023

Retrieval of a Fractured Marathon Microcatheter Entrapped in Onyx Using a Novel Stentriever-Assisted Technique.

Operative neurosurgery (Hagerstown, Md.)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Onyx™ Cast Fragmentation After Embolization of Endoleaks.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2022

Comparative Evaluation of Conventional and OnyxCeph™ Dental Software Measurements on Cephalometric Radiography.

Turkish journal of orthodontics

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Dosimetric comparison of iPlanⓇ Pencil Beam (PB) and Monte Carlo (MC) algorithms in stereotactic radiosurgery/radiotherapy (SRS/SRT) plans of intracranial arteriovenous malformations.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists

Retrospective View Source →
PubMed • 2021

Transradial middle meningeal artery embolization for chronic subdural hematoma using Onyx: case series.

Journal of neurointerventional surgery

Case Series View Source →
PubMed • 2020

Percutaneous transorbital embolization of a carotid cavernous fistula.

Proceedings (Baylor University. Medical Center)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR).

Cardiology journal

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2020

Device profile of the Resolute Onyx Zotarolimus eluting coronary stent system for the treatment of coronary artery disease: overview of its safety and efficacy.

Expert review of medical devices

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is the Glucocard R W Onyx Blood Glucose Monitoring System used for?

It is used to measure blood glucose levels in patients with diabetes for effective management of their condition.

What specialties typically use this device?

Endocrinologists, diabetologists, primary care physicians, and patients themselves commonly use this device.

What are the FDA-cleared indications?

The device is indicated for monitoring blood glucose levels in patients with diabetes to assist in managing their condition.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.